We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted......
(read more)March 28 - Hedge Funds, News - Comments
2018’s fourth quarter was a rough one for investors and many hedge funds, which were naturally unable to overcome the big dip in the broad market......
(read more)January 10 - Hedge Funds, News - Comments
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November. Among them, Facebook......
(read more)December 5 - Hedge Funds, News - Comments
Hedge funds are known to underperform the bull markets but that’s not because they are bad at investing. Truth be told, most hedge fund managers......
(read more)October 24 - Hedge Funds, News - Comments
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse......
(read more)June 19 - Hedge Funds, News - Comments
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or......
(read more)December 10 - Hedge Funds, News - Comments
Warren Buffett’s Firm Invests Millions in Fintech (The Wall Street Journal) Warren Buffett’s Berkshire Hathaway Inc. is hopping on the fintech bandwagon......
(read more)October 29 - Hedge Funds, Insider Trading - Comments
Ken Griffin Hires Two Moore Capital Veterans for Macro Expansion (Bloomberg) Billionaire Ken Griffin hired two veteran money managers from Louis Bacon......
(read more)October 2 - Hedge Funds, Insider Trading - Comments
Famed Value Investor Bill Miller Says Facebook Stock has Gotten Too Cheap: ‘This Too will Pass’ (CNBC) Famed investor Bill Miller is still......
(read more)March 21 - Hedge Funds, Insider Trading - Comments
President Donald Trump in his inaugural speech to a joint session of Congress characterized the approval process of drugs at the U.S. Food and Drug Administration......
(read more)March 2 - News, Stock Analysis - Comments
Amicus Therapeutics, Inc. (NASDAQ:FOLD) says that it will be closing its previously announced private offering of $250 million aggregate principal amount......
(read more)December 22 - News, Stock Analysis - Comments
Amicus Therapeutics, Inc. (NASDAQ:FOLD) just announced a convertible senior notes offering, and the company is trending down on he back of the news. Here......
(read more)December 15 - News, Stock Analysis - Comments
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors......
(read more)December 7 - Hedge Funds, News - Comments
It’s time to take a look at those stocks that really moved over the last twenty-four hours or so in biotech, and there are plenty to go at. It’s been......
(read more)November 29 - Market Movers, News, Stock Analysis - Comments
Despite of all the negative sentiment looming around them, hedge funds had a pretty solid run for much of this year, generating positive returns for seven......
(read more)November 15 - Hedge Funds, News - Comments
While wider markets turn there focus to the US elections, the biotech space is alive and well, and after a tough end to last week, a number of companies......
(read more)November 8 - Market Movers, News - Comments
Joseph Edelman‘s Perceptive Advisors is a fund that has an equity portfolio worth $1.44 billion as of the end of June, with over 80% of it being......
(read more)November 8 - Hedge Funds, News - Comments
The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk......
(read more)October 8 - Hedge Funds, News - Comments
Redmile Group is a San Francisco-based, healthcare-focused hedge fund founded and managed by Jeremy Green, an Oxford alum with more than 20 years of experience......
(read more)June 3 - Hedge Fund Analysis, Hedge Funds, News - Comments
The markets are going nowhere today, after the IMF cut its global growth forecast for the fourth time over the past twelve months, due to China’......
(read more)April 12 - Market Movers, News - Comments
Oil went back to tumbling on Friday, with crude oil losing more than 3.5%. On the other hand, markets returned to positive territory, with major U.S.......
(read more)April 1 - Market Movers, News - Comments
Bloomberg recently came out with its list of best performing hedge funds of 2015 and the fund that managed to beat all its rivals and emerge at the top......
(read more)February 27 - Hedge Funds, News - Comments
Redmile Group is a San Francisco-based investment firm managed by Jeremy Green, which primarily focuses on the healthcare sector. Redmile has an equity......
(read more)February 26 - Hedge Funds, News - Comments
Over the past few months the healthcare sector has undergone a roller coaster of a ride, especially in August and September when many investors got wary......
(read more)December 20 - Hedge Funds, News - Comments
Given elite hedge funds have filed their latest 13F’s, we have an opportunity to analyze what hedge funds like and what they don’t like. Since......
(read more)December 11 - Hedge Funds, News - Comments
The third-quarter stock market correction has turned out to resemble the situation observed during the Asian financial crisis of 1997. The two relatively......
(read more)November 25 - Hedge Funds, News - Comments
Shareholders of Amicus Therapeutics, Inc. (NASDAQ:FOLD), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Novavax, Inc. (NASDAQ:NVAX), and Diamond Offshore......
(read more)November 2 - Market Movers, News - Comments
It’s a good Monday for investors of ContraVir Pharmaceuticals Inc (NASDAQ:CTRV), Amicus Therapeutics, Inc. (NASDAQ:FOLD), and Oasis Petroleum Inc. (......
(read more)October 5 - Market Movers, News - Comments
Three stocks trending significantly low today before afternoon were Amicus Therapeutics, Inc. (NASDAQ:FOLD), which cratered by more than 40%, Teladoc......
(read more)October 2 - Market Movers, News - Comments
Biotech Guru Joseph Edelman‘s Perceptive Advisors is known for its long-short investment approach that focuses on biotech stocks. Edelman founded......
(read more)June 25 - Hedge Funds, News - Comments
Ken Griffin‘s Citadel Investment Group has increased its stakes in Tuesday Morning Corporation (NASDAQ:TUES), Swift Transportation Co (NYSE:SWFT......
(read more)April 28 - Hedge Funds, News - Comments
Jeremy Green‘s Redmile Group has also reduced its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD), after yesterday, William Leland Edwards’......
(read more)October 9 - Hedge Funds, News - Comments
William Leland Edwards’ Palo Alto Investors disclosed today a 50% decrease in its exposure to Amicus Therapeutics, Inc. (NASDAQ:FOLD). According to......
(read more)October 8 - Hedge Funds, News - Comments
Perceptive Advisors, managed by Joseph Edelman, is bullish on Amicus Therapeutics Inc. (NASDAQ:FOLD). In a new filing with the U.S. Securities and Exchange......
(read more)July 2 - Hedge Funds, News - Comments
Jeremy Green‘s Redmile Group has significantly surged its position in Amicus Therapeutics, Inc. (NASDAQ:FOLD), a new filing with the SEC revealed......
(read more)November 29 - Hedge Funds, News - Comments
Is BioDelivery Sciences International, Inc. (NASDAQ:BDSI) a good investment? At the moment, there are many indicators market participants can use to......
(read more)September 17 - News - Comments
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a good investment? Now, according to many investors, hedge funds are assumed to be overrated, outdated investment......
(read more)September 17 - News - Comments
Should Pain Therapeutics, Inc. (NASDAQ:PTIE) investors track the following data? In the eyes of many investors, hedge funds are viewed as overrated,......
(read more)September 6 - News - Comments
Is ZIOPHARM Oncology Inc. (NASDAQ:ZIOP) a buy, sell, or hold? The best stock pickers are taking a bullish view. The number of bullish hedge fund bets......
(read more)June 26 - News - Comments
Amicus Therapeutics, Inc. (NASDAQ:FOLD) was in 12 hedge funds’ portfolio at the end of March. FOLD shareholders have witnessed an increase in enthusiasm......
(read more)June 14 - News - Comments
BioDelivery Sciences International, Inc. (NASDAQ:BDSI) shareholders have witnessed a decrease in hedge fund sentiment of late; stagnant interest is a......
(read more)June 13 - News - Comments
Is Pain Therapeutics, Inc. (NASDAQ:PTIE) a buy, sell, or hold? The smart money is in a bearish mood. The number of long hedge fund positions were trimmed......
(read more)June 10 - News - Comments
Is Amicus Therapeutics, Inc. (NASDAQ:FOLD) a marvelous investment today? Money managers are becoming less confident. The number of bullish hedge fund......
(read more)April 13 - News - Comments
Horse meat and Wal-Mart Stores, Inc. (NYSE:WMT) jockeyed for position in sending the Dow Jones Industrial Average lower on Friday, but the index fought......
(read more)February 20 - News - Comments
With the SPDR S&P Biotech Index up 20% over the trailing-12-month period, it’s evident that investment dollars are willingly flowing into the......
(read more)February 18 - News - Comments
The Ides of March meant bad news for Julius Caesar. Similarly, the week surrounding the Ides of February haven’t turned out so well for several......
(read more)February 16 - News - Comments
Buckeye Partners, L.P. (NYSE:BPL) recently announced plans to issue additional limited partnership units. Citigroup Inc. (NYSE:C) issued preferred shares......
(read more)February 5 - News - Comments
